Expertise in
66
conditions

Dr. Arvinda Padmanabhan

Hematology | Oncology
Baptist Health Medical Group Hematology And Oncology
1780 Nicholasville Rd Ste 101, 
Lexington, KY 
Accepting New Patients
Offers Telehealth
Expertise in
66
conditions
Baptist Health Medical Group Hematology And Oncology
1780 Nicholasville Rd Ste 101, 
Lexington, KY 

Overview

Arvinda Padmanabhan is a Hematologist and an Oncologist practicing medicine in Lexington, Kentucky.

Dr. Padmanabhan is highly rated in 66 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Astrocytoma.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 8 clinical trials. Dr. Padmanabhan is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in KY

Hospital Affiliations

Baptist Health Lexington
Baptist Health Richmond
Baptist Health Corbin
Clark Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Baptist Health Medical Group Hematology And Oncology
1780 Nicholasville Rd Ste 101, Lexington, KY 40503
Other Locations
Baptist Health Medical Group-Palliative Medicine
1700 Nicholasville Rd Ste 1100, Lexington, KY 40503
Lexington Oncology Associates PSC
1720 Nicholasville Rd Ste 701, Lexington, KY 40503

Additional Areas of Focus

Dr. Padmanabhan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Adult Immune Thrombocytopenia
Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2026
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drugs: RRx-001, Cisplatin, Etoposide, Carboplatin, Irinotecan, Vinorelbine, Doxil, Gemcitabine, Taxane, Paclitaxel, Nab-Paclitaxel, Pemetrexed
Study Phase: Phase 2
A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants With Advanced Solid Tumors
A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 1
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: September 01, 2022
Intervention Type: Other
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Enrollment Status: Terminated
Publish Date: February 03, 2021
Intervention Type: Other
View 7 Less Clinical Trials

3 Total Publications

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2021
Similar Doctors
Expertise in
46
conditions
Dr. Firas Badin
Hematology | Oncology
Expertise in
46
conditions
Dr. Firas Badin
Hematology | Oncology
Referral may be required

Baptist Health Medical Group-Palliative Medicine

1700 Nicholasville Rd Ste 1100, 
Lexington, KY 
 (0.1 miles away)
859-276-0414
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Firas Badin is a Hematologist and an Oncologist practicing medicine in Lexington, Kentucky. Dr. Badin is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Badin is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Kentucky Children's Hospital

800 Rose St, 
Lexington, KY 
 (2.3 miles away)
859-257-4488
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Villano is an Oncologist practicing medicine in Lexington, Kentucky. Dr. Villano is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Kentucky Children's Hospital

800 Rose St, 
Lexington, KY 
 (2.3 miles away)
859-257-4488
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Susanne Arnold is an Oncologist practicing medicine in Lexington, Kentucky. Dr. Arnold is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC).

Frequently Asked Questions about Dr. Arvinda Padmanabhan

How do I make an appointment with Dr. Arvinda Padmanabhan?

You can book an appointment with Dr. Arvinda Padmanabhan by calling their office at 859-276-0414. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Arvinda Padmanabhan a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arvinda Padmanabhan is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Arvinda Padmanabhan specialize in?

While Dr. Arvinda Padmanabhan is a Hematology, they have specific expertise in Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Arvinda Padmanabhan participate in research or clinical trials?

Yes. Dr. Arvinda Padmanabhan has published 3 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Arvinda Padmanabhan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Arvinda Padmanabhan accept my insurance?

Dr. Arvinda Padmanabhan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 859-276-0414 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Padmanabhan's expertise for a condition
ConditionClose
    View All 60 Advanced Conditions
    View All 72 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile